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ABSTRACT 
The present study was undertaken to evaluate the anxiolytic and anti-convulsant activity 
of the alcoholic extract of heart wood of Cedrus deodara (ALCD). 50,100 and 200 mg/kg of 
alcoholic extract of Cedrus deodara (ALCD) were tested for its anxiolytic and anticonvulsant 
activity. Elevated plus maze model (EPM), Actophotometre, Light-dark model were used for 
testing anxiolytic activity and Pentylene tetrazole (PTZ) induced convulsions and Maximal 
electro shock (MES) induced convulsions models in mice were used for the assessment of its 
anticonvulsant activity, Pretreatment with ALCD and estimation of GABA in rat brain tissues 
also performed to study the effect of ALCD (30, 100 mg/kg) on GABA levels of brain. In 
Actophotometre test, higher doses (100 and 200mg/kg) of ALCD has showed significant CNS 
depression by reducing locomotor activity in mice.  In EPM the 100 and 200mg/kg of ALCD  
has increased the time spent in the open arm and decreased time spent in the closed arm. In 
Light-dark model the 100 and 200mg/kg of ALCD has showed significant increase in the time 
spent in light zone when compare to the dark zone. In PTZ induced convulsions model 100 and 
200 mg/kg of ALCD has increased the onset of clonus and tonic seizures. 
In MES induced convulsions model 100 and 200 mg/kg of ALCD has decreased 
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duration of tonic extensor phase and also at 100 and 200 mg/kg doses the ALCD has increased 
the percentage protection in PTZ and MES induced convulsions. The ALCD (30 and 100 
mg/kg) also showed significant modulation of GABA levels of cerebellum and whole brain 
other than cerebellum. In conclusion these observations suggest that 100 and 200 mg/kg doses 
of ALCD are having good anxiolytic and anticonvulsant activity. 
 
Keywords: Cedrus deodara, Anxiolytic, Anticonvulsant, GABA estimation. 
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INTRODUCTION 
Anxiety and depression are extremely dramatic and debilitating multifaceted disorders 
and it is now becoming clear that without knowledge of both clinical and biological aspects of 
anxiety and depression, it is impossible to offer effective treatment strategies for the patients. 
Over the past decades, there has been intensive study of a variety of neurobiological aspects of 
depression and anxiety. Mice and human share more than 90% of their genes [1].  
 
Currently the most widely prescribed medications for anxiety disorders are 
Benzodiazepines [2], but the clinical applications of Benzodiazepines as Anxiolytics are limited 
by there unwanted side effects. Therefore the development of new pharmacological agents 
from plant sources is well justified [2]. The use of herbal medications by physicians in Europe 
and Asia is becoming more common and researchers are exploring the traditional remedies to 
find a suitable cure for these mind affecting diseases [3].   
Cedrus is a genus of Pinacea with basically tropical and subtropical worldwide 
distribution, the genus is comprised of trees which are sometimes cultivated either for their 
usefulness to traditional cultures or for ornamental purposes. Traditionally the heartwood of 
Cedrus deodara plant was used to enhance cerebral function, balance the mind, body 
connection, nervous system and strengthen the brain. It was reported to possess CNS 
depressant and neuroleptic activity [4],[5],[6]. So the present study was undertaken to evaluate the 
anxiolytic and anti convulsant activity of the alcoholic extract of heart wood of Cedrus deodara 
(ALCD). 
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MATERIALS AND METHODS 
Drugs and chemicals 
Phenytoin (Sun Pharmaceuticals India.Ltd, Halol. Gujarat. India). Diazepam 
(Ranbaxy Laboratories Ltd, HMTD textiles, India), Pentylene tetrazole (Sigma-Aldrich, 
St.Louis, MO63103, USA) were used for the study. All the solvents used for the extraction 
process are of Laboratory grade and they are purchased from local firms. 
 
Plant extraction 
The heart wood of the plant was purchased from the local market in the month of June 
and authentified by Dr.K.P.Sreenath, Reader and Taxonomist, Botany Department, Bangalore 
University. A sample specimen was deposited, bearing voucher number Coll.no. 
2007/08.CD-I. The shade dried heart wood of the plant was powdered. The coarse powder 
was subjected to successive solvent extraction with petroleum ether, alcohol (70%) in soxhlet 
apparatus. The % yield of Petroleum ether and alcoholic extracts were found to be 13.88% 
and 19.44 % respectively. 
 
Phytochemical investigation 
The alcoholic extract of heart wood of Cedrus deodara (ALCD) was subjected to 
preliminary qualitative investigations [7]. 
 
Experimental animals 
Swiss albino mice of either sex (18-25g) were procured from Bioneeds, Bangalore 
and all were acclimatized for 7 days in the animal house of P.E.S. College of Pharmacy, 
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Bangalore. Male Wistar albino rats (120-150g) were obtained from National Toxicology 
Centre, Pune and were acclimatized at the animal house of Poona College of Pharmacy, 
Pune. All the animals were maintained under standard conditions, i.e. room temperature 26 ± 
10 C, Relative humidity 45-55% and 12:12 h light- dark cycle.  
 
The experimental protocols were approved by the Institutional Animal Ethics 
Committee (IAEC) of PES College of Pharmacy, Bangalore and all the experiments were 
conducted according to the guidelines of Committee for the Purpose of Control and 
Supervision on Experiments on Animals (CPCSEA).  
 
Pharmacological activities 
 
I. Acute toxicity studies 
Acute oral toxicity of alcoholic extract of heart wood of Cedrus deodara was 
determined by using female, nulliparous and non pregnant mice weighing 18-22 g. The 
animals were fasted for 3 hrs prior to the experiment. OECD guideline no. 425 ( Up and 
down procedure ) was adopted for toxicity studies. Animals were administered with single 
dose of extract and observed for their mortality during 48 hours study period (short term) 
toxicity. LD50 was calculated as per OECD guidelines 425 using AOT 425 software 
[8]. 
 
II. Anxiolytic activity  
Elevated Plus Maze  
 The Elevated plus-maze test is described elsewhere. The apparatus comprises of two open 
arms (35 cm ×5 cm) and two closed arms (30 cm × 5 cm ×15cm) that extend from a common 
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central platform (5 cm ×5 cm). The floor and walls of the closed is painted black. The entire 
maze is elevated to height of   50 cm above the floor level. Mice of 18-22g weight were 
housed in pair for 10 days prior to testing in the apparatus. During this time the mice are 
handled by the investigator on alternate days to reduce stress. A group consisting of 6 mice 
was used for each dose level. One hour after oral administration of the vehicle or standard or 
extract, each mouse was placed in the center of the maze facing towards one of the open arm.  
 
 During a five minutes session, the following parameters were noted; Number of entries 
into open arm, Number of entries into closed arm, Time spent in the open arm, and Time 
spent in the closed arm [9],[10],[11]. 
 
Light-dark model  
 Natural aversion of animal for brightly lit places was evaluated in light-dark transition 
model.  Light dark box is a rectangular box of 46 x 27x 30cm (l x b x h), which is divided 
into 2 compartments. 1/3rd is for the dark compartment and 2/3rd is served as light 
compartment. for this Male Swiss albino mice weighing between 18-25g were divided into 
five groups, each group comprising of six animals were used . Vehicle or standard or extract 
was administered orally, One hour after oral administration; the each mouse was placed 
individually in the illuminated part of the Light dark box . The following parameters were 
recorded during the test session of 5 min; Latency to the first crossing to the dark 
compartment, Number of crossings between the light and dark area, Total time spent in the 
illuminated part of the cage and  Total locomotion [12].  
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Actophotometer  
The locomotor activity can be easily studied with the help of actophotometer, for this 
Male Swiss albino mice weighing between 18-25g were divided into five groups, each group 
comprising of six animals, each animal was placed individually and the basal activity score 
was recorded for all the animals. 30 min, 60 min and 120 min after the oral administration of 
the vehicle or Standard or extract each mouse was retested for activity for 10 min.  
The difference in the activity was recorded considering before treatment values and after 
vehicle or standard or extract treatment values. Finally percentage decrease in locomotor 
activity was calculated [13]. 
 
III. Anticonvulsant activity 
 
Pentylenetetrazole induced convulsion  
Male swiss albino mice weighing between 18-25g were divided into five groups, each 
group comprising of six animals, One hour after vehicle or standard or extract treatment, PTZ 
(pentylenetetrazole 80 mg/kg) was administered by intraperitoneally to all the animals. Each 
animal was placed in to individual plastic cage and observed initially for 30min and later up 
to 24 hrs. The following parameters were recorded during test session of initial 30min and up 
to 24 hrs; Latency (onset of clonus), Onset of tonic convulsions, Status of animal after 24 hrs, 
Percentage protection [14]. 
 
Maximal electroshock induced convulsion  
Male swiss albino mice weighing between 18-25g were divided into five groups, each 
group comprising of six animals were used , 30 mins after the oral administration of the 
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vehicle or standard or extract. a 60mA current was delivered transauricularly for 0.2 sec to 
mice via small alligator clips attached to cornea ,then the animals were placed in a 
rectangular plastic cage with an open top permitting full view of animal’s motor responses to 
seizure and the following parameters were recorded during the 30 minutes test session; Tonic 
flexion, Tonic extension, Clonus convulsions, Stupor and Percentage protection. For 
recording various parameters [15]. 
 
IV. Estimation of Gamma-Aminobutyric Acid (GABA) levels in rat brain  
Effect of ALCD on GABA levels in brain was also studied [16]. Briefly, after three 
days treatment with vehicle or standard or extract, the animals were killed by euthanasia and 
the body was exposed to a microwave irradiation for 4 sec.  
 
The brain was rapidly removed ; the cerebellum and the tissue other than cerebellum was 
dissected on an ice-cold petri dish. The tissues were weighed and placed in pre-cooled 100ml 
plastic tubes.  
 
Ice-cooled 0.1M perchloric acid (10 ml) containing valine at a concentration of 15 
µg/ml (internal standard) was added to the tissue. The tissues were homogenized for one 
minute during which the tube was embedded in an ice bath and then centrifuged at 5000 rpm 
for 10 min at 4°C. The supernatants were stored at  -20°C until assayed. Dansylation reaction 
was induced. Dansylation was carried out by adding 100µl of each supernatant of the samples 
or the standards to a micro-tube containing 100µl of 0.1M potassium carbonate solution. 
These solutions were mixed using vortex and then centrifuged using microcentrifuge at 
10000 rpm for 10 min. 100µl of each supernatant was transferred into a pyrex tube containing 
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100µl of 0.1M sodium hydrogen carbonate solution, to which 400µl of working dansyl 
chloride solution (1.25 mg/ml anhydrous acetone) was added. The tubes were shaken for 30 
sec using vortex and then incubated at 90°C in   benchtop oven for 30 min. The tubes were 
not capped during the incubation to allow most of the solvent to be evaporated.  
 
This did not appear to adversely affect the progress of the dansylation reaction and 
served to concentrate the samples. After getting the tubes out of the oven, they were allowed 
to cool down to room temperature and the dansylated derivatives were transferred to 1.5 ml 
microtubes and stored at -20°C until assayed.  
 
C8 reversed-phase HPLC columns (5 µm, 250 x 3.2 mm) were used to resolve and quantify 
the samples. The HPLC mobile phase consisted of deionized helium degassed water-
acetonitrile (HPLC grade) mixture (65:35 v/v) containing 0.15% v/v phosphoric acid. The 
flow rate was kept at 0.5 ml/min.  
The detector excitation was at 333nm and emission at 532nm.  25µl of the dansyl 
derivative of the GABA samples were transferred to HPLC micro-sample vials and injected 
into the column. Retention time of GABA and internal standard were determined.  
The peak ratios of the samples were calculated with reference to the internal standard. GABA 
levels were expressed as ng/g of tissue  
Statistical analysis: 
Values are expressed as mean ± SEM from 6 animals. Statistical differences in mean 
were analyzed using one way ANOVA (analysis of variance) followed by Tukey-kramer test. 
p<0.05 was considered significant. 
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RESULTS 
Phytochemical investigation 
It was found that the alcoholic extract of Cedrus deodara contains alkaloids, 
carbohydrates, proteins, tannins and phenolic compounds. 
Acute toxicity Studies 
Acute toxicity studies was conducted in albino mice according to OECD guidelines no.425 
and LD50  of ALCD was computed to be 1098 mg/kg. 
 
A. Assessment of Anxiolytic Activity 
Elevated plus-maze model 
In elevated plus-maze test (EPM), the alcoholic extract of Cedrus deodara at a dose 
of 50,100 and 200 mg/kg significantly increased the time spent and number of entries in to 
the open arm and decreased the time spent and number of entries in to the closed arm. The 
magnitude of the anxiolytic effects of 100 mg/kg and 200 mg/kg of alcoholic extract of 
Cedrus deodara was comparable to that of diazepam 3 mg/kg p.o. The results are shown in 
the Table no.1.  
 
Light-dark model 
In Light-dark test (LDT), 50, 100 and 200 mg/kg dose of ALCD has increased the 
latency to enter into the dark compartment and time spent in light compartment, confirming 
anxiolytic activity of alcoholic extract of Cedrus deodara at 100 mg/kg and 200 mg/kg. The 
results are shown in the Table no.2. 
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Actophotometer 
In Actophotometer, 100mg/kg and 200mg/kg dose of ALCD significantly reduced 
locomotor activity and 50mg/kg has showed slight reduction in the locomotor activity which 
may be due to the CNS depressant property of the drug.  The results are shown in the Table 
no.3. 
B. Assessment of Anticonvulsant Activity 
Pentylenetetrazole (PTZ) Induced Convulsions 
In Pentylene tetrazole (PTZ) induced convulsion model, ALCD 50, 100 and 200 
mg/kg, p.o doses significantly increased both the onset of clonus and onset of tonic 
convulsions induced by PTZ and also showed significant increase in percentage protection at 
100 and 200 mg/kg doses. The effect was dose dependent. The results are shown in the Table 
no.4. 
 
MES (Maximal Electro Shock) Induced Convulsions 
In Maximal electroshock (MES) induced convulsions model 50, 100 and 200 mg/kg 
doses of ALCD exhibited significant anticonvulsant effect, the extract has showed significant 
decrease in the duration of extensor phase with increase in the latency of clonus in both acute 
and chronic studies and also showed significant increase in percentage protection at 100 and 
200 mg/kg doses.  The results are shown in the Table no.5. 
C. Estimation of GABA levels in rat brain 
 Pretreatment with ALCD (30 and 100 mg/kg, p.o) for seven days had increased 
the GABA levels in cerebellum and whole brain other than cerebellum. Similar effect was 
observed with diazepam (2 mg/kg). However, the effect of ALCD was less than diazepam.  
The results are shown in the Table no.6. 
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Table.1. Effect of ALCD on number of entries and time spent in Elevated Plus-Maze Model 
  (Observation period: 5min for all parameters)   
Values are expressed as mean ± SEM, from 6 mice.  Significant at*P<0.05, **P<0.01 and 
***P<0.001 as compare to control using One way ANOVA followed by Turkey’s post hoc  
test. 
Sl.no Treatment Number of entries 
(counts/5min) 
Time spent  
(counts/5min) 
Time spent in 
neutral zone 
counts/5min)      Open arm Closed arm Open arm Closed arm 
1  Control 
(3%Tween 80) 
6± 0.930 11.67 ± 2.16 53.67 ± 7.491 190.33 ± 8.50 56 ± 14.76 
2 Diazepam 
(3 mg/kg, p.o) 
10.67±0.88***            12.67 ± 0.84 105.66±24.43***   178.833± 4.79 * 16.5 ± 2.40 **            
3 ALCD 
 (50 mg/kg, p.o)  
11.17±0.94*** 11.67 ± 1.38 88.334±13.86*** 195.17 ± 5.72 15.83 ± 3.49 **          
4 ALCD  
(100 mg/kg,p.o) 
12.67±1.22***  10.5 ±  0.67 107.33±2.98** 187.83 ± 8.15 * 6.17 ± 2.07 **            
5 ALCD 
(200 mg/kg,p.o) 
12.17±1.35*** 10.5 ±  0.67 114 ±20.342** 178.83± 8.15 * 7.17± 2.07 **       
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Table.2. Effect of ALCD on various parameters in Light-Dark Model 
 
 
(Observation period: 5min for all parameters)    
Values are expressed as mean ± SEM, from 6 mice.  Significant at *P<0.05, **P<0.01 and 
***P<0.001 as compare to control using one-way ANOVA followed by Tukey-kramer’s post  
hoc test.   
 
 
 
 
 
 
 
 
 
 
 
 
Sl.N Treatment Number of  
entries( Sec) 
Time spent  
in light box 
(Sec) 
Total 
locomotion 
(Counts/5min) 
Defecation 
(Counts/5min) 
No. of rearings  
in Light box 
1 Control 
(3%Tween-80) 
9.834 ± 0.7923  65.8 ± 5.63 291.67 ± 8.460 5.834 ± 1.72 6.5 ± 0.670 
2 Diazepam 
(5 mg/kg, po) 
4.5 ± 0.428*** 176.8±5.68*** 131.67±2.69*** 2.5 ± 0.341*** 2.667 ± 0.6022*** 
3 ALCD 
(50mg/kg, po) 
5.34 ± 0.667*** 124.5± 8.62***      287.5 ± 4.59 4.34 ± 0.61 4.167 ± 0.307* 
4 ALCD 
 (100mg/kg,po) 
4.167 ± 0.47*** 164.8±5.09***  157.5 ± 5.75**  2.833± 0.30** 3.167 ± 0.307*** 
5 ALCD 
 (200mg/kg,po) 
3.834± 0.75*** 171 ± 4.25***  147.5 ± 5.75** 2.334±0.21*** 2.167 ± 0.307*** 
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Table 3. Effect of ALCD on Locomotor activity (Actophotometer) in mice at different time 
intervals(min). 
(Observation period: 10 min for all parameters)    
Values are expressed as mean ± SEM, from 6 mice.  Significant at *P<0.05, **P<0.01 and 
***P<0.001 as compare to control using One way ANOVA followed by Tukey-kramer’s post 
hoc test. 
Sl.No Groups Photocell counts 
30 min % 
Inhibition 
60 min % Inhibition 120 min % Inhibition 
1 Control  
(3%Tween-
80) 
294.5 ±16.69 -- 281±11.43 -- 289±6.23 -- 
2 Diazepam 
 (3mg/kg) 
80.6±15.36*** 72.60 60***±9.21 78.64 64.3±4.29*** 77.73 
3 ALCD 
 (50mg/kg) 
149.1±12.66**
* 
49.34 130.1±3.59*** 53.67 151.5±6.42*
** 
47.57 
4 ALCD  
(100mg/kg) 
167± 19.84*** 3.29 114.5±7.53*** 59.25 109±6.88*** 62.28 
5 ALCD  
(200mg/kg) 
103.3±20.52**
* 
64.91 72.5±9.95*** 74.19 73.6±8.08*** 74.50 
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Table.4. Effect of ALCD on Pentylenetetrazole induced convulsions 
 
 
 
 
 
 
 
 
 
 
 
 
Values are expressed as mean ± SEM, from 6 mice. Significant at **P<0.01 and ***P<0.001 
as compare to control using One way ANOVA followed by Tukey-kramer’s post hoc test. 
 
 
 
 
 
 
 
 
Sl.N 
 
Treatment 
Latency  
(Onset of clonus)  
(Sec) 
Onset Of Tonic 
(Sec) 
Status of   
animal 
(24 hrs, No. of 
animals Alive) 
%Protection (24h) 
1 Control 
 (3% 
tween80) 
49.33 ± 5.32 368.33 ± 17.97 0 0 
2 Diazepam  
(5 mg/kg) 
No clonus No Tonic ALL 100 
3 ALCD  
(50 mg/kg, 
p.o.) 
175 ± 27.29** 672 ± 69.46 ** 1 16.66 
4 ALCD  
(100 mg/kg, 
p.o.) 
265 ± 27.29*** 980 ± 131.15 *** 5 83.33 
5 ALCD  
(200 mg/kg, 
p.o.) 
265 ± 27.29*** 980 ± 131.15 *** ALL 100 
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Table.5. Effect of ALCD on Maximal Electroshock induced convulsions 
 
Values are expressed as mean ± SEM, from 6 mice. Significant at *P<0.05 and ***P<0.001 
as compare to control using one way ANOVA followed by Tukey-kramer’s post hoc test.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Sl.n
o 
Treatment Duration of tonic flexion(sec) Duration of  tonic  
extensor  (sec) 
%protection (24h) 
1 Control  
(3% Tween 80) 
NO 14.17 ± 0.872 16.66 
2 Phenytoin 
 (25 mg/kg) 
5.83 ± 0.9804 NO  *** 100  
3 ALCD 
(50 mg/kg, po) 
NO 8 ± 0.577  33.33 
4 ALCD 
(100 mg/kg, po) 
NO 7.83 ± 0.60* 83.33 
5 ALCD   
(200 mg/kg, po) 
NO 3.83 ± 0.60* 100 
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Table 6:  Effect of ALCD on GABA levels in brain 
 
Values are expressed as mean ± SEM, from 6 mice. Significant at *P<0.05 and ***P<0.001 
as compare to control using one way ANOVA followed by Tukey-kramer’s post hoc test.  
 
Sl.No Treatments In cerebellum 
( ng/g of tissue) 
In whole brain other  
than cerebellum 
( ng/g of tissue) 
1 Control   
(3% Tween 80) 
430.215 ±12.54  2228.83±48.01  
2 Diazepam  
(2mg/kg)  
1873.81±120.75*** 5884.55±124.32***  
3 ALCD 
(30 mg/kg)  
767.42 ±34.75*** 3083.31±195.15*** 
4 ALCD  
(100 mg/kg) 
990.45±43.21*** 3571.97±204.03*** 
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DISCUSSION 
 
Fear and anxiety are defined as the response of a subject to real or particular threats that 
may impair its homeostasis, this response may include physiological or/and behavioral. 
Measuring anxiety like behavior in mice has been mostly undertaken using a few classical 
animal models of anxiety such as the elevated plus maze and Light dark model. All these 
procedures are based upon the exposure of subject to unfamiliar aversive place [17]. 
 
Epilepsy is one of the most common serious neurological conditions. Seizure refers to a 
transient alteration of behaviour due to disordered, synchronous and rhythmic firing of 
populations of brain neurons [18]; the frequency and importance of epilepsy can hardly be 
overstated from the epidemiologic studies. However, in most studies, the overall incidence of 
epilepsy in developed societies has been found to be around 50 cases per 100,000 persons per 
year, and rises steeply in older age [19]. For measuring the anticonvulsant activity in mice has 
been mostly undertaken using a few classical animal models such as the PTZ induced 
convulsions and MES induced convulsions [20],[21]. Studies have proved that the agents which 
increase the brain GABA content and administration of centrally active GABA mimetic agents 
have been used as an effective therapeutic approach for treatment of epilepsy.  
Hence to see the effect of the extract on GABA levels different parts of the brain, the 
animals are treated with the extracts and GABA levels are estimated by HPLC method [16]. 
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The heart wood extracts of Cedrus deodara which have been not studied so for its 
anxiolytic and anticonvulsant activity. In present study the heart wood extracts of Cedrus 
deodara was studied for anxiolytic and anticonvulsant activity by three experimental models 
namely Elevated plus maze test, Light dark model, locomotor activity by actophotometer and 
anticonvulsant activity was studied by using Pentylene tetrazole induced convulsions and MES 
induced convulsions and Pretreatment with ALCD followed by estimation of GABA in rat brain 
tissues was performed to study the effect of ALCD on GABA levels of brain. 
 
The elevated plus maze is currently one of the most widely used models of animal 
anxiety      [9],[10],[11] , the test is principally based on the exposure of animal to an elevated maze 
array evokes an approach-avoidance conflict that is considerably stronger than that evoked by 
exposure to an open maze array. The animals being exposed to the new environment tend to 
avoid open entries and prefer to stay in closed arm due to fear. In our study the ALCD at 50,100 
and 200mg/kg doses has significantly increased the time spent and number of entries in to the 
open arm indicating the test drugs could reduce the fear and anxiety in the mice. In Light dark 
model, ALCD (50,100,200mg/kg) has increased the time spent and number of entries in to the 
light compartment. Anxiolytics should reduce the natural aversion to light, the essential feature 
of this model is that anxiolytic drugs increase the number of crossings and/or the time spent in 
the light compartment.  
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These results suggests that extract administration could reduce the aversion fear and produce 
anxiolytic activity. 
In pentylene tetrazole induced convulsions model[14] the ALCD (100, 200 mg/kg) has 
significantly increased the onset of clonus, onset of tonus and percentage protection when 
compare to control group   and in MES induced convulsions model [15] ALCD (100, 200 mg/kg) 
has significantly decreased the duration of tonic extensor and increased the percentage protection 
when compare to the control group. 
GABA appears to play an important role in the pathogenesis of several neuropsychiatric 
disorders. Many of the traditional agents used to treat psychiatric disorders are known to act, at 
least in part, by enhancing GABA activity, while some of the newer agents may exert their 
therapeutic effects exclusively via GABAergic actions. In our present study, seven days 
treatment with ALCD (30 mg/kg, 100mg/kg.p.o.) and further GABA estimation in brain showed 
significant enhancement of GABA levels in cerebellum and whole brain other than cerebellum 
compared to control group.  
In conclusion, these findings suggest that the alcoholic extract of heartwood of Cedrus 
deodara possess significant anxiolytic and anticonvulsant activity through modulation of GABA 
levels in brain. 
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